Robeco Institutional Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,354
| Closed | -$804K | – | 907 |
|
|
2024
Q4 | $804K | Buy |
4,354
+126
| +3% | +$23.3K | ﹤0.01% | 802 |
|
|
2024
Q3 | $833K | Sell |
4,228
-1,107
| -21% | -$218K | ﹤0.01% | 796 |
|
|
2024
Q2 | $1.1M | Sell |
5,335
-773
| -13% | -$160K | ﹤0.01% | 760 |
|
|
2024
Q1 | $1.65M | Buy |
6,108
+2,758
| +82% | +$747K | ﹤0.01% | 717 |
|
|
2023
Q4 | $792K | Buy |
3,350
+2,700
| +415% | +$638K | ﹤0.01% | 801 |
|
|
2023
Q3 | $127K | Sell |
650
-101
| -13% | -$19.8K | ﹤0.01% | 950 |
|
|
2023
Q2 | $158K | Buy |
751
+276
| +58% | +$58K | ﹤0.01% | 955 |
|
|
2023
Q1 | $95.9K | Buy |
+475
| New | +$95.9K | ﹤0.01% | 980 |
|
|
2022
Q4 | – | Sell |
-475
| Closed | -$94K | – | 965 |
|
|
2022
Q3 | $94K | Sell |
475
-3,904
| -89% | -$773K | ﹤0.01% | 884 |
|
|
2022
Q2 | $938K | Sell |
4,379
-5,623
| -56% | -$1.2M | ﹤0.01% | 706 |
|
|
2022
Q1 | $2.84M | Sell |
10,002
-10,506
| -51% | -$2.98M | 0.01% | 614 |
|
|
2021
Q4 | $7.73M | Sell |
20,508
-110
| -0.5% | -$41.4K | 0.02% | 488 |
|
|
2021
Q3 | $8.51M | Buy |
20,618
+6,125
| +42% | +$2.53M | 0.02% | 485 |
|
|
2021
Q2 | $5.36M | Buy |
+14,493
| New | +$5.36M | 0.01% | 569 |
|